Your eye exam tells you whether you can read tiny letters at twenty feet. That's one slice of vision.
Five common conditions affect a different slice — your contrast sensitivity — sometimes years before they show up on a standard exam.
Contrast sensitivity is how faint a pattern you can still see. The Snellen chart asks one question: how small can the letter be while still being pure black on pure white? Real vision is bigger than that. Faces in evening light, lane lines on wet asphalt, brake lights through fog, a step against a rug — none of those are black on white, and none of them are tested by the eye chart.
The contrast sensitivity function (CSF) is the curve that maps the rest. Campbell and Robson established the framework in 1968: the visual system handles patterns of different sizes through different channels, and a single acuity number samples only one of them (Campbell & Robson, 1968). The five conditions below all degrade other parts of the curve. Some shift it down everywhere. Some carve out a specific band. All of them can do it before acuity drops.
If any of these resonate, the next step isn't a search engine. It's a free contrast sensitivity test, then an eye doctor.
1. Cataract
A cataract is a gradual clouding of the lens. Light scatters inside the eye instead of focusing cleanly on the retina. Contrast washes out.
What you might notice. Night driving feels harder. Headlights wear halos and the road looks washed out after a car passes. Brake lights fuzz at the edges. Reflective signs at dusk take a beat longer to resolve. The eye doctor says 20/20.
What the science shows. Owsley and colleagues followed older drivers with cataract and found that reduced contrast sensitivity was associated with elevated crash risk — and that standard acuity, on its own, was a much weaker predictor (Owsley, Stalvey, Wells, Sloane & McGwin, 2001). The mechanical signature is broad: a global reduction across the curve, worst in the mid-to-high frequencies, with strong symptomatic impact under low light. Importantly, contrast often drops before acuity does. A patient can pass the eye chart and still have a real, measurable deficit that explains the driving difficulty.
Cross-link: Cataract and contrast: why your eye exam might say 20/20 while you struggle to drive at night.
2. Glaucoma
Glaucoma is the leading cause of irreversible blindness worldwide. It is also one of the quietest diseases in ophthalmology — early stages are typically symptom-free.
What you might notice. Usually nothing. That's the problem. Some patients report subtle changes in low-light vision, missed steps on dim staircases, or vague peripheral awareness — but most have no symptoms at all until significant damage has already occurred. Risk climbs sharply after 40, with family history, with Black or Hispanic/Latino ancestry, and with high myopia. A routine exam every one to two years is the actual baseline; a contrast test is an adjunct, not a replacement.
What the science shows. Glaucoma kills retinal ganglion cells, often preferentially the larger ones that feed the magnocellular pathway. That pathway handles low-to-mid spatial frequencies, which means contrast sensitivity in that band can drop before perimetry catches the loss. Kerrigan-Baumrind and colleagues estimated that on the order of 25 to 40 percent of retinal ganglion cells in a given region can be missing before a corresponding visual field defect becomes reliably detectable on standard automated perimetry (Kerrigan-Baumrind, Quigley, Pease, Kerrigan & Mitra, 2000). By the time the field defect is there, the cells are gone for good. Contrast sensitivity is not a substitute for an ophthalmologist — but it can flag the part of vision glaucoma sometimes affects first.
Cross-link: Glaucoma and contrast sensitivity: an underused early signal.
3. Multiple sclerosis
MS demyelinates axons. In the optic pathway, that means nerve impulses arrive temporally smeared and attenuated. The visual system can still pull strong signals (black letters on white) out of the noise. Weak signals (low-contrast edges) are where the damage shows.
What you might notice. After an optic-neuritis episode "resolves" with 20/20 acuity, a residual difference often remains. Faces under dim restaurant light. Reading speed off. A subtle veil in the affected eye that nobody can see but you.
What the science shows. Trobe and colleagues, working with the Optic Neuritis Treatment Trial cohort, compared four vision tests six months after acute optic neuritis. Contrast sensitivity was abnormal roughly 2.2 times more often than acuity, 1.8 times more often than perimetry, and 1.5 times more often than colour vision (Trobe, Beck, Moke & Cleary, 1996). At one year, acuity had recovered to 20/20 or better in about three-quarters of affected eyes — but abnormal contrast sensitivity persisted in more than half. Low-contrast letter acuity is now part of the standard MS clinical-trial endpoint battery for this reason.
Cross-link: Contrast sensitivity in MS: what the research says.
4. Concussion / mild TBI
Most post-concussion visual symptoms are not picked up by the standard eye exam. Acuity-on-the-chart is usually fine. Something else isn't.
What you might notice. Screens are harder to focus on. Headlights at night are harsher than they used to be. Reading speed has dropped enough that you've started re-reading paragraphs. A friend's face across the table at a dim restaurant is somehow more work to recognise than it should be.
What the science shows. Ciuffreda and colleagues reviewed 220 patients with acquired brain injury — most of them mild TBI — and found that roughly 90% had at least one demonstrable oculomotor problem, with acuity-on-the-chart usually untouched (Ciuffreda et al., 2007). Studies of mid-spatial-frequency contrast sensitivity in mTBI consistently document reductions concentrated in the 3-to-12 cpd band — the same band that handles face and edge perception under everyday lighting. The changes can be present even when imaging is unremarkable. A normal CSF doesn't rule out post-concussion visual sequelae (many of them — convergence insufficiency, accommodative dysfunction — need a neuro-optometric exam). A reduced CSF is one objective data point to bring with you.
Cross-link: Vision changes after a concussion: when contrast sensitivity tells you something.
5. Mold / CIRS exposure (contested)
This one needs careful framing. The mold and CIRS community has used a visual contrast test as a screening tool for decades, anchored in Ritchie Shoemaker's clinical work. Mainstream clinical research is skeptical. The honest read is that neither side has settled the question.
What you might notice. Within the framework, patients describe contrast changes alongside fatigue, cognitive complaints, headaches, and a multi-system symptom picture — often after exposure to a water-damaged building.
What the science shows. Contrast sensitivity is a real, well-validated visual measurement. The contested claim is that a reduction in a specific spatial-frequency band (6 and 12 cpd) is a specific signal for biotoxin exposure. The methodology critique, set out most directly by Pelli and Bex in their Vision Research review, is that grating charts with discrete contrast steps — the FACT family used in the original protocol — have ceiling effects and coarse step sizes that limit their ability to detect small changes reliably (Pelli & Bex, 2013). Many other conditions reduce sensitivity in that band: cataract, glaucoma, MS, post-concussion change, refractive error, aging. A reduction is consistent with the framework's pattern; it isn't specific to it. Independent peer-reviewed replication of the specificity claim has not been published at scale.
Cross-link: Mold, CIRS, and the Shoemaker contrast pattern: what is and isn't established.
What to do with this
If any of these resonate, take the test. The result is one data point — not a diagnosis. Bring it to your eye doctor or specialist.
Three small notes. First: a normal CSF doesn't rule any of these conditions out. Second: a reduced CSF is consistent with all of them and with a long list of more common things (refractive error, dry eye, fatigue, aging). Third: the most useful version of this measurement is a trend over time on the same setup, not a single absolute number. Save the result. Re-take in a month. Bring the line, not just the dot.
The right next step is always a clinician. The test is the dot on the i, not the sentence.
Take the test
Take the test now. Free, no signup, three minutes in the quick mode. Runs in your browser. Results stay on your device by default.
If any of the five resonated, the most useful thing you can do today is take the test, save the result, and book an appointment with the right kind of clinician. The post for each condition has the referral guidance.
References
- Campbell, F. W., & Robson, J. G. (1968). Application of Fourier analysis to the visibility of gratings. The Journal of Physiology, 197(3), 551–566. The foundational paper establishing the contrast sensitivity function and the spatial-frequency channel framework.
- Owsley, C., Stalvey, B. T., Wells, J., Sloane, M. E., & McGwin, G., Jr. (2001). Visual risk factors for crash involvement in older drivers with cataract. Archives of Ophthalmology, 119(6), 881–887. Older drivers with cataract and reduced contrast sensitivity were at elevated crash risk; standard acuity was a much weaker predictor.
- Kerrigan-Baumrind, L. A., Quigley, H. A., Pease, M. E., Kerrigan, D. F., & Mitra, R. S. (2000). Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative Ophthalmology & Visual Science, 41(3), 741–748. Source for the estimate that 25–40% of retinal ganglion cells in a given region can be missing before a corresponding visual field defect becomes reliably detectable on standard automated perimetry.
- Trobe, J. D., Beck, R. W., Moke, P. S., & Cleary, P. A. (1996). Contrast sensitivity and other vision tests in the optic neuritis treatment trial. American Journal of Ophthalmology, 121(5), 547–553. Optic Neuritis Treatment Trial analysis comparing four vision tests after acute optic neuritis. Contrast sensitivity was the most likely of the four to remain abnormal after acuity had recovered.
- Ciuffreda, K. J., Kapoor, N., Rutner, D., Suchoff, I. B., Han, M. E., & Craig, S. (2007). Occurrence of oculomotor dysfunctions in acquired brain injury: a retrospective analysis. Optometry, 78(4), 155–161. Retrospective review of 220 patients with acquired brain injury (160 TBI, 60 CVA) finding that roughly 90% had at least one oculomotor dysfunction.
- Pelli, D. G., & Bex, P. (2013). Measuring contrast sensitivity. Vision Research, 90, 10–14. Methodology review of the major contrast sensitivity instruments — ceiling effects, coarse step sizes, and reliability limitations of grating charts with discrete contrast steps (including the FACT family used in the original Shoemaker protocol), plus the precision gains from adaptive procedures.